Test Price
2,800 AED✅ Home Collection Available
CD59 Gene Hemolytic Anemia Genetic Test in Dubai | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified processing and NGS technology.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Genetic Counselling integration provided by Consultant Medical Genetics, Lina Osama Zaki Quteineh (DHA ID: 9294403).
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test screens for pathogenic variants in the CD59 gene, the molecular cause of CD59-mediated hemolytic anemia with or without immune-mediated polyneuropathy. In the UAE, this assay provides a definitive diagnosis, guides targeted management, and informs familial risk assessment under strict regulatory compliance. DNA Labs UAE employs Next Generation Sequencing (NGS) technology to ensure comprehensive coverage of all coding and regulatory regions of the gene.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – full gene coverage including deep intronic regions | Sanger sequencing – limited to exonic regions |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks (variable) |
| Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | May lack international accreditation |
| Cost (AED) | 2,800 | Variable, often higher without insurance |
| Comprehensive Reporting | Includes ACMG variant classification, clinical correlation, and genetic counselling session | Basic pathogenic/likely pathogenic reporting only |
Physician Insight & Safety Protocols
"Patients and families navigating a rare genetic diagnosis often face considerable uncertainty. This NGS test provides a precise molecular answer, enabling personalized management and informed family planning. As a Consultant Medical Genetics, my role is to guide you through these results with clarity and compassion."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)
Important Medication Advisory
⚠️ Critical Advisory: Patients undergoing evaluation for hemolytic anemia must never abruptly stop prescribed immunosuppressants or supportive therapies. Sudden cessation can precipitate an acute hemolytic crisis, requiring immediate emergency intervention. Always consult your referring physician before making any changes to your medication regimen.
Safety Exclusion Criteria & Emergency Red Flags
- This test is specifically designed for individuals with clinical suspicion of CD59 deficiency. It is not a general health screening tool.
- If you are currently experiencing acute hemolysis (dark urine, jaundice, severe fatigue) or rapidly progressive weakness/numbness, proceed to the nearest Emergency Department immediately. Do not wait for genetic test results.
- Emergency Red Flags: sudden confusion, chest pain, difficulty breathing, loss of consciousness, or severe abdominal pain.
Patient FAQ & Clinical Guidance
1. What does the CD59 genetic test detect and who should consider it?
This test identifies pathogenic DNA variants in the CD59 gene that cause hemolytic anemia and immune-mediated nerve damage. It is indicated for patients presenting with unexplained hemolysis, neuropathy, or a family history suggestive of CD59 deficiency. A definitive molecular diagnosis allows for targeted treatment and accurate recurrence risk counseling.
2. How is the sample collected and is fasting required?
A standard peripheral whole blood sample is collected by our VIP Mobile Phlebotomy service at your home or office between 8 AM and 11 PM. No fasting is required for this genetic test. All samples are transported under temperature-controlled cold-chain conditions to ensure genomic stability.
3. How long does it take to receive the results and what support is included?
Results are delivered within 3 to 4 weeks. A telephonic genetic counselling session with Consultant Medical Genetics, Lina Osama Zaki Quteineh, is included to help you interpret your report and coordinate the next steps with your referring physician.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to the UAE's legal frameworks for health data management and patient privacy:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Ensuring the confidentiality and security of your genetic and personal data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Regulating the digital storage, transfer, and processing of health records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Governing clinical safety, informed consent, and professional accountability throughout the diagnostic process.
Clinical & Logistical Metadata
| Test Name | CD59 Gene Hemolytic Anemia Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | D59.8 |
| LOINC Code | 94477-0 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians